These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 114619)

  • 1. Antihypertensive and hemodynamic properties of 2-(3-tert-butylamino-2-hydroxypropoxy)-3-cyanopyridine HCl (MK-761).
    Sweet CS; Scriabine A; Weitz D; Ludden CT; Minsker DH; Stone CA
    J Pharmacol Exp Ther; 1979 Oct; 211(1):200-6. PubMed ID: 114619
    [No Abstract]   [Full Text] [Related]  

  • 2. Antihypertensive effect of nifedipine on conscious renal-hypertensive dogs.
    Hiwatari M; Satoh K; Taira N
    Arzneimittelforschung; 1979; 29(2):256-60. PubMed ID: 582138
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiohemodynamic effects of BAY a 1040 in the dog.
    Hashimoto K; Taira N; Chiba S; Hashimoto K; Endo M
    Arzneimittelforschung; 1972 Jan; 22(1):15-21. PubMed ID: 5066992
    [No Abstract]   [Full Text] [Related]  

  • 4. Vasodilator and antihypertensive actions of 3-nitropropionic acid.
    Hong E; Castillo C; Rivero I; Somanathan R
    Proc West Pharmacol Soc; 1990; 33():209-11. PubMed ID: 2125725
    [No Abstract]   [Full Text] [Related]  

  • 5. Heterocyclic analogues of the antihypertensive beta-adrenergic blocking agent (S)-2-[3-(ter-butylamino)-2-hydroxypropoxy]-3-cyanopyridine.
    Baldwin JJ; Engelhardt EL; Hirschmann R; Ponticello GS; Atkinson JG; Wasson BK; Sweet CS; Scriabine A
    J Med Chem; 1980 Jan; 23(1):65-70. PubMed ID: 6102151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the hypotensive action of prazosin.
    Constantine JW; McShane WK; Scriabine A; Hess HJ
    Postgrad Med; 1975 Nov; Spec No():18-35. PubMed ID: 1197141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolic disposition of (S)-2-(3-tert-butylamino-2-hydroxypropoxy)-3-cyanopyridine in rats, dogs, and humans.
    Vickers S; Duncan CA; Arison BH; Davies RO; Ferguson R; Zacchei AG
    Drug Metab Dispos; 1980; 8(3):163-7. PubMed ID: 6104580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic profile of the antihypertensive vasodilator cadralazine in conscious dogs.
    Dorigotti L; Ferni G; Lombroso M; Semeraro C
    Arzneimittelforschung; 1984; 34(9):984-7. PubMed ID: 6542375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent knowledge in the pathophysiology, pathogenesis and hemodynamics of arterial hypertension as a base for scientifically founded diagnosis and therapy].
    Wedler B
    Z Arztl Fortbild (Jena); 1984; 78(24):1011-8. PubMed ID: 6528646
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of the vasodilator action of antihypertensive drug budralazine.
    Chiba T; Hirohashi M; Suzuki I; Tanaka S; Watanabe K; Akashi A
    Arzneimittelforschung; 1983; 33(1):112-6. PubMed ID: 6299307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological studies of N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride (MDL-899), a new long-acting antihypertensive vasodilator.
    Baldoli E; Bianchi G; Corsico N; Di Francesco GF
    Arzneimittelforschung; 1985; 35(5):818-26. PubMed ID: 2862874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of adenosine di-phosphate (ADP).
    Hoie J
    J Oslo City Hosp; 1973; 23(6):111-8. PubMed ID: 4771836
    [No Abstract]   [Full Text] [Related]  

  • 13. Diuretic and antihypertensive effects of 2-aminoethyl-4-(1,1-dimethylethyl)-6-iodophenol hydrochloride (MK-447).
    Scriabine A; Watson LS; Russo HF; Ludden CT; Sweet CS; Fanelli GM; Bohidar NR; Stone CA
    J Pharmacol Exp Ther; 1979 Jan; 208(1):148-54. PubMed ID: 759610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of antihypertensive drugs.
    Itskovitz HD
    Am Fam Physician; 1983 Jun; 27(6):137-42. PubMed ID: 6134461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive and cardiac effects of two novel beta-adrenoceptor blocking drugs.
    Scriabine A; Ludden CT; Morgan G; Baldwin JJ
    Experientia; 1979 Dec; 35(12):1634-7. PubMed ID: 42553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemodynamic indices in patients with hypertension].
    Andrushchenko EV; Krasovskaia EA; Glukhovskaia GF; Rubaĭ IN; Polishchuk II
    Vrach Delo; 1983 Jul; (7):64-6. PubMed ID: 6624062
    [No Abstract]   [Full Text] [Related]  

  • 17. Antihypertensive and other cardiovascular effects of 2-(3-pyridyl)- and 2-(4-pyridyl)-4-trifluoromethylimidazoles.
    Scriabine A; Ludden CT; Watson LS; Stavorski JM; Morgan G; Baldwin JJ
    Experientia; 1979 May; 35(5):653-5. PubMed ID: 446671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the influence of the antihypertensive drug urapidil on blood circulation and its regulation in animal experiments (author's transl)].
    Schoetensack W; Bischler P; Dittmann EC; Steinijans V
    Arzneimittelforschung; 1977; 27(10):1908-19. PubMed ID: 579101
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemodynamic effects of Bay a 1040 before and after atropine administration].
    Lydtin H; Lohmöller R
    Verh Dtsch Ges Inn Med; 1972; 78():1554-9. PubMed ID: 4665607
    [No Abstract]   [Full Text] [Related]  

  • 20. Antihypertensive and hemodynamic actions of SCH 19927, the R,R-isomer and labetalol.
    Baum T; Watkins RW; Sybertz EJ; Vemulapalli S; Pula KK; Eynon E; Nelson S; Vliet GV; Glennon J; Moran RM
    J Pharmacol Exp Ther; 1981 Aug; 218(2):444-52. PubMed ID: 7252843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.